Navigation Links
Nebraska Medical Center Implants State's First SynCardia Total Artificial Heart

TUCSON, Ariz., April 18, 2013 /PRNewswire/ -- SynCardia Systems, Inc. (, manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that The Nebraska Medical Center in Omaha has performed the state's first implant of the SynCardia temporary Total Artificial Heart to save the life of 42-year-old Greg Rathe (photo) and bridge him to a second heart transplant.

Watch video of Greg Rathe 's story -

"Greg had chronic rejection of his donated heart," said Mike Moulton , MD, chief of cardiothoracic surgery and heart transplant surgeon at The Nebraska Medical Center. "That process affected both the left and right ventricles. Because his heart had deteriorated to such a degree, a Total Artificial Heart was the only option."

In 1996, Rathe received a heart transplant after a sudden onset of viral cardiomyopathy, a weakening of the heart muscle. After 17 years of life with his donor heart, his symptoms returned earlier this year.

"I used to run a frontend loader at a limestone quarry," said Rathe, who enjoys fishing and welding yard ornaments and toys. "I felt weak and couldn't breathe. When I got here, to the Med Center, they said I'd need a new heart."

Rathe was listed for a heart transplant in September 2012. According to his doctors, donor hearts have become available twice since then, but neither were a good match for Rathe, whose immune system is overactive due to his first heart transplant.

This March, with his donor heart failing, Rathe's condition became critical when he lost consciousness and collapsed.

"We knew if we didn't move forward with the Total Artificial Heart, Greg would not survive," said John Um , MD, surgical director of cardiac transplantation and mechanical circulatory support at The Nebraska Medical Center.

To save Rathe's life, on March 14, Drs. Moulton and Um performed the state's first implant of the SynCardia Total Artificial Heart.

Now that he's on the road to recovery, Rathe's hopes for the future are simple: "Help take care of my son. He's only 4. So I can watch him grow up. Go back to work… live a normal life."

View news coverage of The Nebraska Medical Center's first implant -
Read press release from The Nebraska Medical Center -

About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure). There have been more than 1,100 implants of the Total Artificial Heart, accounting for more than 300 patient years of life.

Similar to a heart transplant, the SynCardia Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

Forbes Ranks SynCardia #69 Among "America's Most Promising Companies"
In its February 2013 issue, Forbes selected SynCardia as one of "America's Most Promising Companies" for the second consecutive year. On the list of 100 privately held, high-growth companies with bright futures, SynCardia was selected #69, moving up eight spots from its #77 ranking last year. See the full list of SynCardia Awards & Recognition here.

For additional information, please visit:
Like SynCardia on Facebook - 
Follow SynCardia on Twitter –
Connect with SynCardia on LinkedIn - 

SOURCE SynCardia Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Bayer CropScience Bee Care Tour Stops in Nebraska
2. Pinnaclife To Sponsor The Nebraska Academy of Nutrition and Dietetics Fuel Up With Color 5K And 1 Mile Fun Run
3. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
4. BioClinica Releases Integrated Medical Image Management Solution
5. Surefire Medical Launches Next Generation Infusion System ST-LT and Specialty Catheters at SIR - Maximizing Targeted Delivery of Embolics Without Reflux
6. AtheroNova Adds New Medical Advisor
7. Nanotherapeutics Awarded Defense Department Contract for Advanced Development and Manufacturing of Medical Countermeasures
8. “Scientific And Medical Research On The Successful Treatment Of Type 1 + 2 Diabetes With Alkaline Reduced Water” is Reviewed in Today’s Bawell Water Ionizer Health Report
9. Dermatology Associates Medical Group in Beverly Hills Announces Safe, Fast Anti-Aging Laser Treatment
10. ICMs New Blue Gene Supercomputer Supports The Largest Biomedical Research Initiative In Poland
11. Medical Marijuana Inc., Corporate Update- Significant Revenue and Net Income Growth 1st Quarter- Division and Corporate Holdings Update
Post Your Comments:
(Date:6/27/2016)... CA (PRWEB) , ... June 27, 2016 , ... ... for clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT ... care circle with the physician and clinical trial team. , Using the CONSULT module, ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
Breaking Biology Technology:
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
Breaking Biology News(10 mins):